

Bharat Serums And Vaccines Profile
Key Indicators
- Authorised Capital ₹ 352.16 Cr
- Paid Up Capital ₹ 7.31 M
- Company Age 31 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 466.00 Cr
- Satisfied Charges ₹ 65.00 Cr
- Revenue Growth 16.98%
- Profit Growth 420.76%
- Ebitda 51.86%
- Net Worth 2.26%
- Total Assets 1.21%
About Bharat Serums And Vaccines
Bharat Serums And Vaccines Limited (BSAVL) is a leading Public Limited Indian Non-Government Company incorporated in India on 11 November 1993 and has a history of 31 years and four months. Its registered office is in Thane, Maharashtra, India.
The Corporate was formerly known as Aksipro Diagnostics P Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 352.16 Cr and a paid-up capital of Rs 7.31 M.
The company currently has active open charges totaling ₹466.00 Cr. The company has closed loans amounting to ₹65.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Bharat Serums And Vaccines Limited India are Anupama Pai as Company Secretary, Chirag Mehta as Cfo, and Sanjiv Navangul as Ceo. Rajeev Juneja, Sheetal Arora, Arjun Juneja, and Two other members serve as directors at the Company.
Company Details
- Location
Thane, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U74110MH1993PLC075088
- Company No.
075088
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
11 Nov 1993
- Date of AGM
12 Aug 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Bharat Serums And Vaccines?
Executive Team (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sanjiv Navangul ![]() | Managing Director | 06-Feb-2020 | Current |
Anupama Pai ![]() | Company Secretary | 22-Sep-2021 | Current |
Chirag Mehta ![]() | CFO | 22-Sep-2021 | Current |
Board Members (4)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Rajeev Juneja ![]() | Additional Director | 23-Oct-2024 | Current |
Sheetal Arora ![]() | Additional Director | 23-Oct-2024 | Current |
Arjun Juneja ![]() | Additional Director | 23-Oct-2024 | Current |
Anju Jha ![]() | Additional Director | 18-Feb-2025 | Current |
Financial Performance of Bharat Serums And Vaccines.
Bharat Serums And Vaccines Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 16.98% increase. The company also saw a substantial improvement in profitability, with a 420.76% increase in profit. The company's net worth moved up by a moderate rise of 2.26%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Bharat Serums And Vaccines?
In 2024, Bharat Serums And Vaccines had a promoter holding of 99.72% and a public holding of 0.28%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Related Corporates (Common Directorship)
- S M Creative Electronics Limited
Anju Jha is a mutual person
- Phd Chamber Of Commerce And Industry
Rajeev Juneja is a mutual person
- Packtime Innovations Private Limited
Anju Jha is a mutual person
- Relax Pharmaceuticals Private Limited
Anju Jha is a mutual person
- Copmed Pharmaceuticals Private Limited
Anju Jha is a mutual person
- The Hi-Tech Gears Limited
Arjun Juneja is a mutual person
Charges (Loans)
₹466.00 Cr
₹65.00 Cr
Charges Breakdown by Lending Institutions
- Citi Bank N.A. : 225.00 Cr
- Others : 135.00 Cr
- Axis Bank Limited : 65.00 Cr
- Idbi Bank Limited : 35.00 Cr
- Hdfc Bank Limited : 6.00 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
15 Oct 2024 | Citi Bank N.A. | ₹200.00 Cr | Open |
29 Jun 2024 | Others | ₹25.00 Cr | Open |
18 Nov 2022 | Citi Bank N.A. | ₹25.00 Cr | Open |
09 Sep 2021 | Hdfc Bank Limited | ₹6.00 Cr | Open |
20 Aug 2021 | Others | ₹85.00 Cr | Open |
How Many Employees Work at Bharat Serums And Vaccines?
Bharat Serums And Vaccines has a workforce of 1786 employees as of Mar 21, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Bharat Serums And Vaccines, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bharat Serums And Vaccines's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Bharat Serums And Vaccines
Recent activity within the organization
- Director Appointment
Anju Kumari Jha was appointed as a Additional Director was appointed as a Additional Director on 18 Feb 2025 & has been associated with this company since 1 month 8 days .
- Director Appointment
Sanjiv Hari Navangul was appointed as a Ceo was appointed as a Ceo on 11 Feb 2025 & has been associated with this company since 1 month 15 days .
- Director Appointment
Rajeev Juneja was appointed as a Additional Director was appointed as a Additional Director on 23 Oct 2024 & has been associated with this company since 5 months 6 days .
- Director Appointment
Sheetal Arora was appointed as a Additional Director was appointed as a Additional Director on 23 Oct 2024 & has been associated with this company since 5 months 6 days .
- Director Appointment
Arjun Juneja was appointed as a Additional Director was appointed as a Additional Director on 23 Oct 2024 & has been associated with this company since 5 months 6 days .
- Charges
A charge with Citi Bank N.A. amounted to Rs. 200.00 Cr with Charge ID 100996203 was registered on 15 Oct 2024.
Recent News, Updates & Announcement
- BSV and Amp Energy India Partner to Achieve Sustainable Goals and Save Money for Pharma Industry with Solar Power Plant.
BSV saves money and the environment with solar power plant. Amp Energy India helps BSV achieve sustainability goals and reduce carbon footprint. Pharma industry can also go green and save money. Thanks BSV and Amp Energy India for making it happen. #SustainableGoals #GoGreen #SaveMoney #PharmaIndustry.
- Advent International emerges sole bidder for Bharat Serums.
Kotak PE and OrbiMed together hold 23% stake in BSV. The rest of the stake is with the Daftary family. .
- Exclusive: Mankind Pharma, Bharat Serums joint venture on the cards? .
Promoters of Bharat Serums and Vaccines (BSV) are reconsidering their plan to exit their 50-year old business for around Rs 3,500 crore. .
- Carlyle-Zydus and Advent join race to acquire Bharat Serums and Vaccines Ltd.
They are up against domestic pharma companies Dr Reddy's Labs, Mankind & Goldman Sachs which have also made offers..
Frequently asked questions
What is the Incorporation or founding date of Bharat Serums And Vaccines Limited?
Bharat Serums And Vaccines Limited was incorporated on 11 Nov 1993.
What is authorized share capital and paid-up capital of Bharat Serums And Vaccines Limited?
The authorized share capital of Bharat Serums And Vaccines Limited is ₹ 352.16 Cr and paid-up capital is ₹ 7.31 M.
Who are the current board members & directors of Bharat Serums And Vaccines Limited?
Currently 8 directors are associated with Bharat Serums And Vaccines Limited.
- Rajeev Juneja
- Sheetal Arora
- Arjun Juneja
- Sanjiv Hari Navangul
- Anju Kumari Jha
- Anupama Diwakar Pai
- Chirag Ashokbhai Mehta
- Sanjiv Hari Navangul
What is the registered address of Bharat Serums And Vaccines Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Bharat Serums And Vaccines Limited is 3Rd Floor Liberty Tower Plot No. K-10 Behind Reliable Plaza Kalwa Industrial Estate, India, Thane, Maharashtra, 400708.
What is the corporate identification number (CIN) and company number of Bharat Serums And Vaccines Limited?
The corporate identification number (CIN) of Bharat Serums And Vaccines Limited is U74110MH1993PLC075088 and the company number is 075088 as per Ministry of Corporate Affairs (MCA).
What is the official website of Bharat Serums And Vaccines Limited?
The Official website of Bharat Serums And Vaccines Limited is https://www.bsvgroup.com
What has been the recent revenue trend for Bharat Serums And Vaccines Limited?
According to the financial reports for the fiscal year 2024, the revenue trend for Bharat Serums And Vaccines Limited has risen by 16.98%.
How many employees does Bharat Serums And Vaccines Limited currently have?
As Per 2024 financial reports, 1786 employees are currently employed by Bharat Serums And Vaccines Limited.
What change has been observed in the net worth of Bharat Serums And Vaccines Limited, and by what percentage?
The financial reports for the fiscal year 2024 indicates that The net worth of Bharat Serums And Vaccines Limited has experienced an upsurge of 2.26%.
What are the total open charges for Bharat Serums And Vaccines Limited?
As per the financial statements for fiscal Year 2024, The total open charges for Bharat Serums And Vaccines Limited amount to ₹ 466.00 Cr.
When was the last Balance Sheet of Bharat Serums And Vaccines Limited filed with the ROC?
The most recent Balance Sheet for Bharat Serums And Vaccines Limited was filed with the ROC on 31 Mar 2024.
People also Viewed
- Surendra LuniaAdditional Director
- Pankaj PatwariDirector
BD
Bharat DaftaryDirectorSJ
Shweta JalanDirectorBI
Bhaskar IyerDirectorJM
Jayesh MerchantDirectorVA
Venkata AlladiDirectorAM
Abhijit MukherjeeDirector